These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 23459556)
1. Iron overload favors the elimination of Leishmania infantum from mouse tissues through interaction with reactive oxygen and nitrogen species. Vale-Costa S; Gomes-Pereira S; Teixeira CM; Rosa G; Rodrigues PN; Tomás A; Appelberg R; Gomes MS PLoS Negl Trop Dis; 2013; 7(2):e2061. PubMed ID: 23459556 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis. Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571 [TBL] [Abstract][Full Text] [Related]
6. Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection. Marques F; Vale-Costa S; Cruz T; Marques JM; Silva T; Neves JV; Cortes S; Fernandes A; Rocha E; Appelberg R; Rodrigues P; Tomás AM; Gomes MS Parasit Vectors; 2015 Dec; 8():644. PubMed ID: 26684322 [TBL] [Abstract][Full Text] [Related]
7. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Freitas CS; Oliveira-da-Silva JA; Lage DP; Costa RR; Mendonça DVC; Martins VT; Reis TAR; Antinarelli LMR; Machado AS; Tavares GSV; Ramos FF; Coelho VTS; Brito RCF; Ludolf F; Chávez-Fumagalli MA; Roatt BM; Ramos GS; Munkert J; Ottoni FM; Campana PRV; Humbert MV; Coimbra ES; Braga FC; Pádua RM; Coelho EAF Parasitol Res; 2021 Jan; 120(1):321-335. PubMed ID: 33191446 [TBL] [Abstract][Full Text] [Related]
8. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. Costa RR; Oliveira-da-Silva JA; Reis TAR; Tavares GSV; Mendonça DVC; Freitas CS; Lage DP; Martins VT; Antinarelli LMR; Machado AS; Bandeira RS; Ludolf F; Santos TTO; Brito RCF; Humbert MV; Menezes-Souza D; Duarte MC; Chávez-Fumagalli MA; Roatt BM; Coimbra ES; Coelho EAF Med Microbiol Immunol; 2021 Jun; 210(2-3):133-147. PubMed ID: 33870453 [TBL] [Abstract][Full Text] [Related]
9. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468 [TBL] [Abstract][Full Text] [Related]
10. Miltefosine-Lopinavir Combination Therapy Against Rebello KM; Andrade-Neto VV; Gomes CRB; de Souza MVN; Branquinha MH; Santos ALS; Torres-Santos EC; d'Avila-Levy CM Front Cell Infect Microbiol; 2019; 9():229. PubMed ID: 31316919 [TBL] [Abstract][Full Text] [Related]
11. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection. Honoré S; Garin YJ; Sulahian A; Gangneux JP; Derouin F FEMS Immunol Med Microbiol; 1998 Jul; 21(3):231-9. PubMed ID: 9718213 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684 [TBL] [Abstract][Full Text] [Related]
13. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis. Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866 [TBL] [Abstract][Full Text] [Related]
14. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum. Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi. Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156 [TBL] [Abstract][Full Text] [Related]
17. Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B. Valdivieso E; Mejías F; Carrillo E; Sánchez C; Moreno J Int J Antimicrob Agents; 2018 Nov; 52(5):682-687. PubMed ID: 29969693 [TBL] [Abstract][Full Text] [Related]
18. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum. Da Silva BJM; Souza-Monteiro JR; Rogez H; Crespo-López ME; Do Nascimento JLM; Silva EO Biomed Pharmacother; 2018 Jan; 97():1613-1621. PubMed ID: 29793323 [TBL] [Abstract][Full Text] [Related]
19. Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice. Silva SC; Silva DF; Almeida TC; Perasoli FB; da Silva ATP; da Silva GN; Rezende SA Parasitol Res; 2018 Sep; 117(9):2881-2893. PubMed ID: 29943317 [TBL] [Abstract][Full Text] [Related]
20. Effects of nitro-heterocyclic derivatives against Leishmania (Leishmania) infantum promastigotes and intracellular amastigotes. Petri e Silva SC; Palace-Berl F; Tavares LC; Soares SR; Lindoso JA Exp Parasitol; 2016 Apr; 163():68-75. PubMed ID: 26795261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]